2024年8月1日 · The CA 27.29 test is an important tool for monitoring the treatment and care of metastatic breast cancer. The test can be used to monitor your response to treatment and/or assess whether cancer is active or spreading, but it has its limitations.

2023年6月7日 · The cancer antigen 27.29 test (CA 27.29) is a blood test that measures the levels of glycoprotein produced by the mucin-1 (MUC1) gene. The level of CA 27.29, also known as 27.29, is used as a tumor marker to measure the activity of the disease in patients with breast cancer. It’s one of several types of tumor markers used for breast cancer ...

2024年2月13日 · CA 27-29 levels, in conjunction with the history, physical examination, and diagnostic imaging findings, are typically used to monitor treatment response of metastatic breast cancer. A decrease...

An elevated serum CA 27.29 level in patients in remission of stage II or III breast cancer provided a positive predictive value of 83.3% for recurrent disease, with an average lead time of 5.3 months before recurrence was clinically established.

The cancer antigen 27.29 test (CA 27.29) is a blood test that measures the levels of glycoprotein produced by the mucin-1 (MUC1) gene. The level of CA 27.29, also known as 27.29, is used as a tumor marker to measure the activity of the disease in patients with breast cancer.

Cancer Antigen 27.29 (CA 27.29) is a protein that can be released into the bloodstream by certain cancer cells, especially breast cancer cells. It is often used as a tumor marker, meaning it can be checked through blood tests to keep track of cancer's status.

This test measures how much CA 27-29 is in your blood. Antigens like CA 27-29 that give information about cancer are called tumor markers. Breast cancer is the cancer most likely to release CA 27-29. The FDA has approved the CA 27-29 blood test as a way for healthcare providers to check people with breast cancer. Why do I need this test?

Test Information: The CA 27.29 assay is intended for use in monitoring: 1) disease progression and/or response to therapy in patients with metastatic disease, and 2) disease recurrence in patients treated previously for stages II or III breast carcinoma who …

The FDA has approved the CA 27-29 blood test as a way for healthcare providers to check people with breast cancer. Why do I need this test? CA 27-29 is not a screening test to find out whether you have breast cancer.

For the CA 27.29 blood test, anything that is below 40 units per milliliter [U/ml] is considered to be a normal result. This means that women who have different test results that stay below 40 shouldn’t be concerned about the outcomes. A result that is 18 one day and then 26 on the next test both qualify as normal results.